Kynam Capital Management, LP - 30 Sep 2025 SCHEDULE 13G/A Report for Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

Filing Manager
Kynam Capital Management, LP
Reporting Manager
Kynam Capital Management, LP
Security
Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Symbol
BNR
Shares outstanding
9,036,176 shares
Disclosed Ownership
994,883 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 12:37:11 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Quoteable Key Fact

"Kynam Capital Management, LP disclosed 11% ownership in Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) on 30 Sep 2025."

Quick Takeaways

  • Kynam Capital Management, LP filed SCHEDULE 13G/A for Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR).
  • Disclosed ownership: 11%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 12:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kynam Capital Management, LP 11% 994,883 0 994,883 Yue Tang Managing Member
Kynam Capital Management GP, LLC 11% 994,883 0 994,883 Yue Tang Managing Member
Yue Tang 11% 994,883 0 994,883 Yue Tang Self
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .